Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Covington
Express Scripts
Fish and Richardson
Cipla
Julphar
QuintilesIMS
Chubb
Johnson and Johnson

Generated: February 18, 2018

DrugPatentWatch Database Preview

BRISTACYCLINE Drug Profile

« Back to Dashboard

Which patents cover Bristacycline, and what generic alternatives are available?

Bristacycline is a drug marketed by Bristol and is included in two NDAs.

The generic ingredient in BRISTACYCLINE is tetracycline hydrochloride. There are ninety-nine drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the tetracycline hydrochloride profile page.

US Patents and Regulatory Information for BRISTACYCLINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol BRISTACYCLINE tetracycline hydrochloride CAPSULE;ORAL 061658-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol BRISTACYCLINE tetracycline hydrochloride CAPSULE;ORAL 061888-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol BRISTACYCLINE tetracycline hydrochloride CAPSULE;ORAL 061888-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bristol BRISTACYCLINE tetracycline hydrochloride CAPSULE;ORAL 061658-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Colorcon
Farmers Insurance
Baxter
Harvard Business School
Cipla
Covington
Teva
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot